Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Doxorubicin + Dual Checkpoint Blockade for Soft Tissue Sarcoma
Recruiting1 awardPhase 2
Aurora, Colorado
This trial tests a combination of chemotherapy and immune-boosting drugs in cancer patients. The goal is to see if this combination works better than chemotherapy alone by helping the body's natural defenses fight cancer more effectively. Combination therapies of chemotherapy and immunotherapy have shown promising results in initial studies, with potential synergistic effects enhancing anti-tumor immunity.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service